J F Lovera

Summary

Affiliation: Louisiana State University Health Sciences Center
Country: USA

Publications

  1. doi request reprint Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
    Jesus Lovera
    Department of Neurology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA, United States Electronic address
    J Neurol Sci 358:46-52. 2015
  2. doi request reprint Stress in multiple sclerosis: review of new developments and future directions
    Jesus Lovera
    Department of Neurology, LSU Health Sciences Center New Orleans, 1542 Tulane Avenue, Room 718A, New Orleans, LA, 70112, USA
    Curr Neurol Neurosci Rep 13:398. 2013
  3. pmc Cognitive impairment in multiple sclerosis
    Jesus Lovera
    Department of Neurology, Louisiana State University Health Sciences Center New Orleans, 1542 Tulane Ave, Rm 718A, New Orleans, LA 70112, USA
    Curr Neurol Neurosci Rep 12:618-27. 2012
  4. pmc Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial
    Jesus F Lovera
    Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, USA
    Neurology 79:1278-84. 2012
  5. doi request reprint Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
    J F Lovera
    Neurology, Louisiana State University Health Sciences Center, New Orleans, LA 70003, USA
    Mult Scler 16:715-23. 2010

Detail Information

Publications5

  1. doi request reprint Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
    Jesus Lovera
    Department of Neurology, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA, United States Electronic address
    J Neurol Sci 358:46-52. 2015
    ..Correlate plasma levels of EGCG with neuroprotective effects. Phase II (PhII): Further assess safety and confirm the neuroprotective effects of Polyphenon E...
  2. doi request reprint Stress in multiple sclerosis: review of new developments and future directions
    Jesus Lovera
    Department of Neurology, LSU Health Sciences Center New Orleans, 1542 Tulane Avenue, Room 718A, New Orleans, LA, 70112, USA
    Curr Neurol Neurosci Rep 13:398. 2013
    ..Additional work is needed to improve the duration of this effect and make this therapy more widely accessible. ..
  3. pmc Cognitive impairment in multiple sclerosis
    Jesus Lovera
    Department of Neurology, Louisiana State University Health Sciences Center New Orleans, 1542 Tulane Ave, Rm 718A, New Orleans, LA 70112, USA
    Curr Neurol Neurosci Rep 12:618-27. 2012
    ..We need more work to understand better CI in MS and develop treatments for this serious complication of MS...
  4. pmc Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial
    Jesus F Lovera
    Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, USA
    Neurology 79:1278-84. 2012
    ..To determine whether Ginkgo biloba extract (ginkgo) improves cognitive function in persons with multiple sclerosis (MS)...
  5. doi request reprint Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial
    J F Lovera
    Neurology, Louisiana State University Health Sciences Center, New Orleans, LA 70003, USA
    Mult Scler 16:715-23. 2010
    ..Memantine, an NMDA antagonist, is effective for moderate to severe Alzheimer's disease...